Pneumococcal vaccination by general practitioners: An evaluation of current practice

Vaccine

Volumn 18, Issue 7-8, 1999, Pages 612-617

  Peetermans, Willy E ^a   Lacante, Paul ^b  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b Wyeth Lederle Belgium   (Belgium)

Author keywords

Physician's practice patterns; Pneumococcal vaccine; Vaccination

Indexed keywords

INFLUENZA VACCINE; PNEUMOCOCCUS VACCINE;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; FEMALE; GENERAL PRACTICE; GENERAL PRACTITIONER; HEALTH PROMOTION; HUMAN; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEASONAL VARIATION; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE; TREATMENT INDICATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BACTERIAL VACCINES; BELGIUM; CHILD; CHILD, PRESCHOOL; FAMILY PRACTICE; FEMALE; HUMANS; MALE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; PNEUMOCOCCAL VACCINES; PNEUMONIA, PNEUMOCOCCAL; PRACTICE GUIDELINES; VACCINATION;

EID: 0032729485     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(99)00312-6     Document Type: Article

References (18)

1. Advisory Committee on Immunization Practices. Prevention of pneumococcal disease. MMWR Morbidity and Mortality Weekly Report 1997, 46 RR-8, 1-24.
2. Fedson D.S. Adult immunization: summary of the national vaccine advisory committee report. JAMA. 272:1994;1133-1137.
3. Gardner P., Schaffner W. Immunization of adults. New England Journal of Medicine. 328:1993;1252-1258.
4. Jernigan D.B., Cetron M.S., Breiman R.F. Minimizing the impact of drug-resistant Streptococcus pneumoniae. A strategy from the DRSP working group. JAMA. 275:1996;206-209.
5. Verhaegen J., Gluczynski Y., Verbist L., Blogie M., Verbiest N., Vandeven J., Yourassowsky E. Capsular types and antibiotic susceptibility of pneumococci isolated from patients in Belgium with serious infections, 1980-1993. Clinical Infectious Diseases. 20:1995;1339-1345.
6. Shapiro E.D., Berg A.T., Austrian R., Schroeder D., Parcells V., Margolis A., Adair R.K., Clemens J.D. The protective efficacy of polyvalent pneumococcal polysaccharide vaccine. New England Journal of Medicine. 325:1991;1453-1460.
7. Butler J.C., Breiman R.F., Campbell J.F., Lipman H.B., Broome C.V., Facklam R.R. Pneumococcal polysaccharide vaccine efficacy. An evaluation of current recommendations. JAMA. 270:1993;1826-1831.
8. Fine M.J., Smith M.A., Carson C.A., Meffe F., Sankey S.S., Weissfeld L.A., Detsky A.S., Kapoor W.N. Efficacy of pneumococcal vaccination in adults. Archives of Internal Medicine. 154:1994;2666-2677.
9. Fedson D.S. Pneumococcal vaccination in the United States and 20 other developed countries, 1981-1996. Clinical Infectious Diseases. 26:1998;1117-1123.
10. Peetermans W., Bachez P., Peleman R., Vanatoru J., Van Laethem Y., Struelens M., Verhaegen J. Belgian consensus on pneumococcal vaccine. Acta Clinica Belgica. 51:1996;350-356.
11. Fedson D.S., Hirota Y., Shin H.K., et al. Influenza vaccination in 22 developed countries: an update in 1995. Vaccine. 15:1997;1506-1511.
12. Honkanan P.O., Keistinen T., Kivelä S.L. The impact of vaccination strategy and methods of information on influenza and pneumococcal vaccination coverage in the elderly population. Vaccine. 15:1997;317-320.
13. Govaert T.M.E., Thijs C.T.M.C.N., Masurel N., Sprenger M.J.W., Dinant G.J., Knottnerus J.A. The efficacy of influenza vaccination in elderly individuals. JAMA. 272:1994;1661-1665.
14. McDonald P., Friedman E.H.I., Banks A., Anderson R., Carman V. Pneumococcal vaccine campaign based in general practice. British Medical Journal. 314:1997;1094-1098.
15. Fedson D.S. Influenza and pneumococcal vaccination in Canada and the United States, 1980-1993: what can the two countries learn from each other ? Clinical Infectious Diseases. 20:1995;1371-1376.
16. Sisk J.E., Moskowitz A.J., Whang W., Lin J.D., Fedson D.S., McBean A.M., Plouffe J.F., Cetron M.S., Butler J.C. Cost-effectiveness of vaccination against pneumococcal bacteremia among elderly people. JAMA. 278:1997;1333-1339.
17. Lombaert G, De Graeve D, Goossens H. Een economische evaluatie van het pneumokokkenvaccin voor België (An economical evaluation of the pneumococcal vaccine for Belgium). Report 97/342, February 1997.
18. Baltussen R.M.P.M., Ament A.J.H.A., Leidl R.M., van Furth R. Cost-effectiveness of vaccination against pneumococcal pneumonia in the Netherlands. European Journal of Public Health. 7:1997;153-161.